The Latest in Recap

Optimizing Biomarker Testing in Non–Small Cell Lung Cancer

September 5, 2023

Endocrine Therapy Resistance in HR+/HER2- Breast Cancer

May 1, 2023

Optimal Use of CDK4/6 Inhibitors in Breast Cancer

March 29, 2023

Frontline Treatment for Advanced HR+/HER2- Breast Cancer

March 23, 2023

Therapeutic Approaches in Advanced Breast Cancer

December 15, 2022

Treating High-Risk, Early-Stage HR+/HER2- Breast Cancer

April 29, 2022

Breast Cancer

Selecting Between CDK4/6 Inhibitors in Advanced HR+/HER2- Breast Cancer

April 1, 2022

Breast Cancer

Use of Biomarkers to Optimize Treatment of NSCLC

October 1, 2021

Lung Cancer

Therapeutic Approaches in Advanced Breast Cancer

July 7, 2021

Optimal Treatment for HR+/HER2- Breast Cancer Patients With Visceral Metastasis

June 1, 2021

Breast Cancer

Latest Treatment Options in HR+/HER2- Advanced Breast Cancer in Postmenopausal Women

March 1, 2021